Welcome to the August issue of The Highlight

GLP-1 drugs like Ozempic, Wegovy, and Mounjaro have been wildly successful. But as popular as they are, Americans still have very negative feelings about the people using them. In this month’s Highlight cover story, Dylan Scott explains why ‘Ozempic stigma’ hasn’t gone away, how it’s impacting GLP-1 users, and whether it could begin to fade as more and more people take the drugs. Also in this issue: How to tolerate uncertainty. What rent freezes could mean for renters. Good news about declining road deaths. And the coming AI wealth boom. Can knowing less make you happier? By Shayla Love The simple idea that helped prevent millions of traffic deaths By Bryan Walsh The one thing Ozempic still can’t fix By Dylan Scott How to tolerate uncertainty in a world that’s full of it By Elizabeth Weingarten The truth about rent control By Marina Bolotnikova Rise of the AI-ristocracy By Sara Herschander Coming August 6